ReviewCurrent oncology reports2013
Latest developments in the biology and management of uveal melanoma.
Review in Current oncology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.Journal of cancer research and clinical oncology · 2024Article
- Novel treatment paradigms for metastatic uveal melanoma.Cancer gene therapy · 2022Article
- [Screening of drugs that selectively inhibit uveal melanoma cells with SF3B1 mutations].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021Article
- Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma.Frontiers in cell and developmental biology · 2021Article
- Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.Journal for immunotherapy of cancer · 2020Article
- MSK1 promotes cell proliferation and metastasis in uveal melanoma by phosphorylating CREB.Archives of medical science : AMS · 2020Article
- Tumour Expression of Histone Deacetylases in Uveal Melanoma.Ocular oncology and pathology · 2019Article
- Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.American journal of clinical oncology · 2018Article
- Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p.PloS one · 2017Article
- Clinical presentation and management of uveal melanoma.Molecular and clinical oncology · 2016Article
- Immunotherapy for uveal melanoma.Melanoma management · 2016Review
- Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.Scientific reports · 2016Article
- Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.American journal of translational research · 2016Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24122445What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.